Jaguar Health, Inc.

JAGX

Jaguar Health, Inc.

JAGX

Insider Sentiment (TTM):

Last Purchase:2022-12-31Last Sale:2021-06-04Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:240,918Shares Outstanding:515,788Institutional Ownership Pct.:46.71%

Earnings Market Reaction:

Filing Date:2026-08-19Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Series G Convertible Preferred Stock	-	-	-	0	0	0	0	0	0	0	0	0
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	4	7	1	4	2	6	8	13	16	12	6	3
Restricted Cash Current	3	3	7	-	-	-	0	-	-	-	-	-
Accounts Receivable Net Current	0	0	2	1	1	1	2	1	1	2	2	2
Other Receivables Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Inventory Net	7	8	9	11	11	11	10	10	10	9	9	8
Prepaid Expense And Other Assets Current	3	2	2	14	14	13	12	12	13	11	10	9
Assets Current	18	20	20	29	28	30	32	37	40	34	28	22
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	1
Operating Lease Right Of Use Asset	1	1	1	1	1	1	1	1	1	1	1	1
Intangible Assets Net Excluding Goodwill	15	16	16	17	18	18	18	19	19	20	20	21
Other Assets	0	0	0	1	1	1	1	1	0	0	1	1
Assets	34	37	38	49	48	51	53	58	61	55	51	45
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	5	5	9	8	7	7	5	5	4	3	5	5
Accrued Liabilities Current	5	4	4	4	4	2	2	3	3	3	4	3
Contract With Customer Liability Current	0	0	0	0	0	0	0	0	0	0	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	1
Notes Payable Current	14	22	27	23	19	19	12	11	11	10	5	4
Liabilities Current	25	41	41	36	29	28	20	20	19	18	14	12
Operating Lease Liability Noncurrent	1	1	1	1	1	1	1	1	1	1	1	0
Contract With Customer Liability Noncurrent	0	0	0	0	0	1	1	1	1	1	-	-
Derivative Liabilities Noncurrent	0	0	-	-	-	-	-	-	-	-	-	-
Long Term Notes Payable	2	11	15	8	11	18	24	22	22	22	31	31
Liabilities	29	53	57	45	41	48	44	43	42	41	46	44
Temporary Equity Carrying Amount Attributable To P…	-	-	-	0	0	2	2	2	2	2	-	-
Stockholders Equity
Additional Paid In Capital Common Stock	412	378	381	381	374	359	354	351	344	330	314	301
Minority Interest	-2	-2	-1	-1	-1	-1	-1	-1	-0	-0	-0	0
Retained Earnings Accumulated Deficit	-404	-391	-400	-377	-367	-357	-346	-337	-327	-317	-308	-299
Accumulated Other Comprehensive Income Loss Net Of…	-1	-1	-1	-1	-1	-1	-0	-1	-1	-0	-1	-1
Stockholders Equity	5	-16	-19	4	7	1	6	13	17	12	5	1
Liabilities And Stockholders Equity	34	37	38	49	48	51	53	58	61	55	51	45
Common Stock	-	0	0	-0	-0	0	0	-0	0	0	0	0
Series H Convertible Preferred Stock	-	-	-	-	-	-	0	0	0	0	0	-2
Convertible Non Voting Common Stock	-	-	-	-	-	-	0	-	-	-	0	-
Notes Payable Fair Value Disclosure	-	-	-	-	-	-	-	-	-	-	31	30
Temporary Equity Par Or Stated Value Per Share	-	-	-	0	0	0	0	0	0	0	0	-
Temporary Equity Shares Authorized	-	-	-	10	10	10	10	10	10	10	10	-
Series J Redeemable Preferred Stock	-	-	0	-	-	-	0	-	-	-	-	-
Convertible Preferred Stock Series B Two	-	-	-	-	-	-	0	-	-	-	0	-
Series C Perpetual Preferred Stock	-	-	-	-	-	-	1	-	-	-	1	-
Series I Convertible Preferred Stock	-	-	0	0	0	0	0	0	0	0	0	0
Series B Convertible Preferred Stock	-	-	-	-	-	-	0	-	-	-	0	-
Series K Junior Participating Preferred Stock	-	-	-	-	-	0	-	-	-	-	-	-
Series L Perpetual Preferred Stock	-	0	0	0	0	-	0	-	-	-	-	-
Series M Perpetual Preferred Stock	-	0	0	0	0	-	0	-	-	-	-	-
Series N Perpetual Preferred Stock	-	0	0	0	-	-	0	-	-	-	-	-
Series O Convertible Preferred Stock	-	0	-	-	-	-	-	-	-	-	-	-
Common Stock Voting	-297	298	0	2	2	0	0	0	0	0	0	0
Nonvoting Common Stock	-	0	0	0	-0	0	0	0	0	0	0	0
Common Stock Shares Issued	-	-	-	-	-	-	-	-	-	-	-	26
Preferred Stock Shares Authorized	4	10	10	10	10	10	10	10	10	10	10	-
Temporary Equity Shares Issued	-	-	-	0	0	0	0	0	0	0	0	-
Temporary Equity Shares Outstanding	-	-	-	0	0	0	0	0	0	0	0	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-26.70%	-37.06%	-74.11%	-	-	-	-	-	-	-	-	-
2025	-26.18%	-53.09%	-64.00%	-14.49%	5.80%	-6.28%	-39.33%	-43.93%	-62.08%	-53.38%	-75.26%	-79.02%
2024	-78.12%	-78.24%	-92.97%	3.74%	19.63%	-0.93%	-3.24%	16.40%	-10.53%	129.20%	-5.67%	-41.18%
2023	-	-	-	-	-	-	-20.18%	-57.83%	-70.78%	133.77%	0.22%	-15.15%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.69	0.50	0.50	0.81	0.95	1.08	1.63	1.84	2.10	1.89	2.00	1.77
Quick Ratio	0.27	0.25	0.23	0.14	0.12	0.25	0.49	0.73	0.91	0.75	0.62	0.41
Working Capital	-7.85M	-20.48M	-20.31M	-6.72M	-1.32M	2.23M	12.49M	16.77M	20.98M	15.90M	13.98M	9.60M
Leverage & Debt
Debt to Equity	5.95	-3.38	-3.05	10.35	6.02	58.01	6.84	3.27	2.56	3.48	9.37	31.05
Interest Coverage TTM	-25.95	-30.87	-219.66	-175.52	-95.76	-73.48	-31.11	-26.78	-21.65	-6.79	-5.37	-3.51
Debt Ratio	0.86	1.42	1.49	0.91	0.86	0.94	0.83	0.73	0.69	0.74	0.90	0.97
Efficiency & Turnover
Asset Turnover TTM	0.67	0.67	0.25	0.22	0.22	0.22	0.22	0.20	0.18	0.18	0.20	0.22
Days Sales Outstanding TTM	7.75	7.97	48.32	41.59	38.20	43.21	54.55	50.90	48.31	44.98	71.91	59.56
Receivables Turnover TTM	47.10	45.81	7.55	8.78	9.56	8.45	6.69	7.17	7.56	8.12	5.08	6.13
Per Share Metrics
Diluted EPS TTM	-64.43	-96.93	-22.97	-26.71	-1,411.67	-2,226.43	-130.69	-102.03	-10.11	-367.58	-2,717.14	-115.59
Free Cash Flow Per Share TTM	-8.26	-14.62	-10.16	-17.34	-961.96	-1,669.01	-100.55	-77.44	-8.25	-286.55	-2,155.63	-97.82
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	82.31%	85.06%	67.21%	81.92%	81.88%	82.34%	83.27%	80.10%	79.79%	79.07%	79.13%	82.79%
Operating Profit Margin TTM	-93.10%	-88.96%	-398.82%	-278.52%	-278.13%	-277.33%	-263.76%	-288.46%	-311.79%	-322.10%	-351.31%	-307.99%
Net Profit Margin TTM	-187.43%	-169.08%	-465.42%	-342.90%	-346.57%	-345.07%	-329.30%	-364.91%	-354.70%	-383.88%	-429.27%	-372.68%
Growth Metrics
Net Revenue Growth (1Y)	135.52%	155.96%	-1.52%	12.45%	15.95%	13.93%	19.75%	-2.25%	-7.89%	-10.29%	-18.36%	-0.50%
Net Income Growth (1Y)	27.38%	25.42%	39.18%	5.67%	13.30%	2.41%	-8.14%	-4.28%	-18.95%	-6.59%	-11.70%	-26.29%
EPS Growth (1Y)	-95.44%	-95.65%	-82.42%	-73.83%	13,861.91%	505.70%	-95.19%	-11.73%	-93.33%	4,407.31%	7,409.54%	202.40%
Valuation Metrics
P/E TTM	-0.05	-0.13	-1.42	-3.05	-0.06	-0.07	-6.76	-11.58	-309.81	-12.85	-2.92	-118.09
P/B TTM	0.49	-0.43	-4.07	28.31	0.37	3.59	40.08	33.80	675.13	42.34	24.96	3,332.07
P/S TTM	0.09	0.23	6.60	10.47	0.22	0.26	22.27	42.25	1,098.91	49.34	12.52	440.09
Market Cap	2.43M	6.70M	76.00M	123.40M	2.56M	2.98M	260.29M	442.74M	11.19B	500.35M	122.25M	4.72B
Enterprise Value	11.40M	29.79M	110.69M	150.63M	29.66M	34.36M	287.83M	462.62M	11.21B	520.80M	151.64M	4.75B
Calculated Values
Free Cash Flow TTM	-6.69M	-7.54M	-23.69M	-26.24M	-27.89M	-29.88M	-29.62M	-29.03M	-29.47M	-30.34M	-33.24M	-33.81M
Net Debt	8.97M	23.09M	34.69M	27.23M	27.11M	31.38M	27.54M	19.88M	16.88M	20.44M	29.39M	31.44M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2022-12-31Purchase

Owner: Wolin, Jonathan S.

Title: Chief of Staff, CCO & GC

Shares: 317

Price/Share: $0.03

Value: $9.51

Shares Owned: 6,983

Relationship: Officer

Ownership: Direct

2021-09-13Purchase

Owner: Lizak, Carol R.

Title: Chief Financial Officer

Shares: 7,968

Price/Share: $2.51

Value: $19,999.68

Shares Owned: 7,968

Relationship: Officer

Ownership: Indirect

2021-09-13Purchase

Owner: Conte, Lisa A

Title: CEO and President

Shares: 7,968

Price/Share: $2.51

Value: $19,999.68

Shares Owned: 8,003

Relationship: Director,Officer

Ownership: Direct

2021-06-04Sale

Owner: Bochnowski, James J

Title: -

Shares: 152

Price/Share: $1.74

Value: $264.48

Shares Owned: 954,390

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2022-12-31	Wolin, Jonathan S.	Officer	Chief of Staff, CCO & GC	Direct	Purchase	317	0.03	$9.51	6,983	4
2021-09-13	Lizak, Carol R.	Officer	Chief Financial Officer	Indirect	Purchase	7,968	2.51	$19,999.68	7,968	4
2021-09-13	Conte, Lisa A	Director,Officer	CEO and President	Direct	Purchase	7,968	2.51	$19,999.68	8,003	4
2021-06-04	Bochnowski, James J	Director	-	Direct	Sale	152	1.74	$264.48	954,390	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

46.71%

Inst. Shares: 240,918

Shares Outstanding: 515,788

2025-12-31

2.81%

Inst. Shares: 65,515

Shares Outstanding: 2,332,401

2025-09-30

6.30%

Inst. Shares: 95,300

Shares Outstanding: 1,513,178

2025-06-30

1.35%

Inst. Shares: 13,684

Shares Outstanding: 1,014,783

2025-03-31

28.23%

Inst. Shares: 5,055

Shares Outstanding: 17,904

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	240,918	515,788	46.71%
2025-12-31	65,515	2,332,401	2.81%
2025-09-30	95,300	1,513,178	6.30%
2025-06-30	13,684	1,014,783	1.35%
2025-03-31	5,055	17,904	28.23%
2024-12-31	234,150	294,534	79.50%
2024-09-30	249,732	374,805	66.63%
2024-06-30	91,624	3,572,984	2.56%
2024-03-31	5,826,286	105,895	-
2023-12-31	1,095,078	15,421	-
2023-09-30	566,035	345,657	163.76%
2023-06-30	407,220	293,858	138.58%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Jaguar Health, Inc. (JAGX) — SEC Financial Statements & Analysis

Jaguar Health, Inc. (JAGX) is a pharmaceutical preparations company, incorporated in DE. Jaguar Health, Inc. trades on Nasdaq as: JAGX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Jaguar Health, Inc. reported a 135.52% year-over-year revenue growth, a Gross Profit Margin of 82.31% (TTM), a Debt-to-Equity ratio of 5.95x, a Price-to-Sales (P/S) ratio of 0.09x (TTM), a Price-to-Book (P/B) ratio of 0.49x (TTM), at a market cap of $2.43M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 135.52%
Gross Profit Margin TTM: 82.31%
Debt To Equity: 5.95x
P/S TTM: 0.09x
P/B TTM: 0.49x
Market Cap: $2.43M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Jaguar Health, Inc. in?

Jaguar Health, Inc. (JAGX) operates in the Pharmaceutical Preparations industry.

What is JAGX's market cap?

Jaguar Health, Inc. (JAGX) has a market capitalization of $2.43M as of 2026-06-30.

What exchange does JAGX trade on?

Jaguar Health, Inc. (JAGX) trades on the Nasdaq.

Where is Jaguar Health, Inc. incorporated?

Jaguar Health, Inc. is incorporated in DE.